Maridebart cafraglutide trials for Overweight

All Maridebart cafraglutide trials · All Overweight trials

Phase breakdown

Recruiting trials studying Maridebart cafraglutide for Overweight

• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
  NCT07037433 · Phase: Phase 3 · Ages: 45 Years to 99 Years · Sex: All (male and female) · 782 locations
• Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
  NCT07684235 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 87 locations
• Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
  NCT07684144 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 74 locations

Common questions

How many trials study Maridebart cafraglutide for Overweight?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.